PROXEON BIOSYSTEMS ApS: Financial statements 2012
CVR: 26848024
Source: annual report 2012, Danish Business Authority
01/01/2012 – 31/12/2012
PROXEON BIOSYSTEMS ApS (CVR 26848024) has filed annual accounts for 2012. In 2012, the company reported a gross profit of DKK 37,938,144 and a net result of DKK 22,032,998. Equity in the 2012 report amounted to DKK 62,980,362. The solvency ratio was 86.7%. The company had 36 employees in the financial year.
- Gross Profit
- DKK 37,938,144
- Profit/Loss
- DKK 22,032,998
- Equity
- DKK 62,980,362
- Total Assets
- DKK 72,601,232
- Employees
- 36
Keep an eye on PROXEON BIOSYSTEMS ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2012
As of April 11, 2012, Iain Alasdair Keith Moodie has joined the board of directors of PROXEON BIOSYSTEMS ApS.
As of April 11, 2012, James R. Coley has left the board of directors of PROXEON BIOSYSTEMS ApS.
About PROXEON BIOSYSTEMS ApS
PROXEON BIOSYSTEMS ApS is a Danish company of the type Anpartsselskab based in Roskilde, founded in 2002. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Simon Lie. The company is owned by NUNC A/S. The company has 0 employees (2013). In 2025, the company reported a gross profit of DKK 0 and a net result of DKK 2,950,000 compared with DKK 3,703,000 the year before. Equity in the 2025 report amounted to DKK 386,590,000.